| Dr Akbar Razvi, AUD, CCC/A | |
|
660 N Westmoreland Rd, Lake Forest, IL 60045-1659 | |
| (847) 535-6114 | |
| (847) 535-7809 |
| Full Name | Dr Akbar Razvi |
|---|---|
| Gender | Male |
| Speciality | Qualified Audiologist |
| Experience | 15 Years |
| Location | 660 N Westmoreland Rd, Lake Forest, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184884413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 147.001274 (Illinois) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | 147.001274 (Illinois) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.
Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.
These rules, along with others related to the environment and worker safety, were delayed to avoid introducing contentious issues into the 2012 campaign, The Washington Post reports.
A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.
› Verified 1 days ago
| Provider Name | Rush University Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.
Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.
These rules, along with others related to the environment and worker safety, were delayed to avoid introducing contentious issues into the 2012 campaign, The Washington Post reports.
A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Akbar Razvi, AUD, CCC/A 660 N Westmoreland Rd, Lake Forest, IL 60045-1659 Ph: (847) 535-6114 | Dr Akbar Razvi, AUD, CCC/A 660 N Westmoreland Rd, Lake Forest, IL 60045-1659 Ph: (847) 535-6114 |
News Archive
In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.
A vaccine in development against the H5N1 influenza virus can produce a safe immune response in healthy people at low doses, according to an article published by The Lancet.
Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.
These rules, along with others related to the environment and worker safety, were delayed to avoid introducing contentious issues into the 2012 campaign, The Washington Post reports.
A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.
› Verified 1 days ago
Mrs. Madonna Nmi Stoioff, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 660 N Westmoreland Rd, Lake Forest, IL 60045 Phone: 846-535-6114 Fax: 847-535-7809 | |
Monica Thomas, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 800 N Westmoreland Rd Ste 102, Lake Forest, IL 60045 Phone: 847-535-6464 | |
Dr. Darrin Alan Worthington, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 660 N Westmoreland Rd, 800 Building, Lake Forest, IL 60045 Phone: 847-535-6554 Fax: 847-535-7809 | |
Dr. Caroline Rose Brennan, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 267 E Westminster, Lake Forest, IL 60045 Phone: 847-295-1185 | |
Dr. Jennifer Schumacher, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 660 N Westmoreland Rd, Building 800- Ll 30, Lake Forest, IL 60045 Phone: 847-535-6553 | |
Kiran Silwal, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 225 E Deerpath Ste 223, Lake Forest, IL 60045 Phone: 847-295-1185 |